Form D · Other Health Care
EpiWatch, Inc.
Baltimore, MD · CIK 0001861587
Offering snapshot reported Aug 19, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $500K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 9, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 22, 2024 | Initial | $190,000 | No comparison | 6 | SEC filing |
| Jul 11, 2024 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jan 22, 2024 | Initial | $300,000 | No comparison | 10 | SEC filing |
| Nov 2, 2023 | Initial | $55,000 | No comparison | 2 | SEC filing |
| Jun 6, 2023 | Initial | $340,000 | No comparison | 9 | SEC filing |
| Sep 12, 2022 | Initial | $250,000 | No comparison | 10 | SEC filing |
| Mar 7, 2022 | Initial | $415,000 | No comparison | 9 | SEC filing |
| May 13, 2021 | Amendment | $450,000 | $0vs May 11, 2021 | 5 | SEC filing |
| May 11, 2021 | Initial | $450,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594694
Series 9 convertible note with a common stock equity kicker
Source: Form D, filed Aug 19, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nathan Crone | Director, Executive, Promoter |
| Daniel Hanley | Director |
| Gregory Krauss | Director, Executive, Promoter |
| Dean Papadopoulos | Director, Executive, Promoter |
| Teresa Prego | Director, Executive |
| Richard Schmitt | Director |
| Michael E. Singer | Director |
| Robert Smith | Director |
| Richard Thomas | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1812 Ashland Avenue Suite 110
Baltimore, MD, 21205
Baltimore, MD, 21205